Starting Dose of Lantus (Insulin Glargine)
Start Lantus at 10 units once daily at the same time each day, administered subcutaneously, and titrate upward every 3 days based on fasting blood glucose levels. 1
Rationale for Initial Dosing
With an A1C of 10%, this patient has significantly uncontrolled diabetes despite oral therapy. The FDA-approved starting dose for insulin-naive type 2 diabetes patients is 10 units once daily (or 0.2 units/kg) 1. This aligns with the 2025 American Diabetes Association guidelines, which recommend starting basal insulin at 10 units per day OR 0.1-0.2 units/kg per day 2.
Given the patient's high A1C (10%), the ADA guidelines specifically note that insulin should be considered when "A1C or blood glucose levels are very high (i.e., A1C >10%)" 2. This patient meets criteria for urgent insulin initiation.
Titration Strategy
Use an evidence-based titration algorithm: increase by 2 units every 3 days to reach fasting plasma glucose goal without hypoglycemia 2. The target fasting blood glucose should be <100 mg/dL (5.5 mmol/L).
Specific Titration Steps:
- Measure fasting blood glucose daily
- If fasting glucose remains elevated after 3 days, increase dose by 2 units
- Continue this pattern until fasting glucose reaches target
- If hypoglycemia occurs: determine the cause; if no clear reason, lower dose by 10-20% 2
Important Considerations with Current Medications
Glimepiride Twice Daily
The patient is on glimepiride BID, which increases hypoglycemia risk when combined with insulin. Monitor closely for hypoglycemia, particularly nocturnal hypoglycemia 3, 4. Research shows that glimepiride plus insulin glargine is effective, with studies demonstrating mean HbA1c reductions of 1.5-1.65% 5, 4, but hypoglycemia monitoring is essential.
Low-Dose Metformin (500 mg daily)
The patient's metformin dose is suboptimal but they refuse to increase it. While this is not ideal, combination therapy with insulin glargine plus metformin (even at low doses) plus glimepiride has been studied and shows efficacy 6, 7. Research suggests that when combining insulin with metformin, slightly lower insulin doses may be needed (0.37 units/kg vs 0.40 units/kg for insulin monotherapy) 8, though starting at 10 units remains appropriate per FDA labeling.
Critical Safety Points
- Prescribe glucagon for emergent hypoglycemia 2
- Rotate injection sites within the same region (abdomen, thigh, or deltoid) to reduce lipodystrophy risk 1
- Administer at the same time daily - can be morning or bedtime based on patient preference 4
- Never administer intravenously or via insulin pump - subcutaneous only 1
- Do not mix or dilute with other insulins 1
Expected Outcomes
With proper titration, expect:
- HbA1c reduction of approximately 1.3-1.6% 3, 5
- Achievement of fasting glucose <100 mg/dL in many patients
- Final insulin dose typically 30-40 units daily 5, 4
Common Pitfall to Avoid
Clinical inertia in dose titration is the most common error. The 2025 ADA guidelines explicitly warn against therapeutic inertia and recommend reassessing and modifying therapy regularly (every 3-6 months) 2. Don't leave the patient on 10 units indefinitely - aggressive titration every 3 days is necessary to achieve glycemic control.